| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-82 |
Sentence |
denotes |
A novel strategy to generate biologically active neo-glycosaminoglycan conjugates. |
| T1 |
0-82 |
Sentence |
denotes |
A novel strategy to generate biologically active neo-glycosaminoglycan conjugates. |
| T1 |
0-82 |
Sentence |
denotes |
A novel strategy to generate biologically active neo-glycosaminoglycan conjugates. |
| TextSentencer_T2 |
83-199 |
Sentence |
denotes |
Heparin and heparan sulfate are structurally related polysaccharides with a variety of biological effects/functions. |
| T2 |
83-199 |
Sentence |
denotes |
Heparin and heparan sulfate are structurally related polysaccharides with a variety of biological effects/functions. |
| T2 |
83-199 |
Sentence |
denotes |
Heparin and heparan sulfate are structurally related polysaccharides with a variety of biological effects/functions. |
| TextSentencer_T3 |
200-337 |
Sentence |
denotes |
Most of these effects are due to interactions, of varying specificity, between the negatively charged polysaccharide chains and proteins. |
| T3 |
200-337 |
Sentence |
denotes |
Most of these effects are due to interactions, of varying specificity, between the negatively charged polysaccharide chains and proteins. |
| T3 |
200-337 |
Sentence |
denotes |
Most of these effects are due to interactions, of varying specificity, between the negatively charged polysaccharide chains and proteins. |
| TextSentencer_T4 |
338-562 |
Sentence |
denotes |
While such interactions generally involve a single saccharide domain of decasaccharide size or less, ternary complexes of two protein molecules binding to separate domains on a single polysaccharide chain are known to occur. |
| T4 |
338-562 |
Sentence |
denotes |
While such interactions generally involve a single saccharide domain of decasaccharide size or less, ternary complexes of two protein molecules binding to separate domains on a single polysaccharide chain are known to occur. |
| T4 |
338-562 |
Sentence |
denotes |
While such interactions generally involve a single saccharide domain of decasaccharide size or less, ternary complexes of two protein molecules binding to separate domains on a single polysaccharide chain are known to occur. |
| TextSentencer_T5 |
563-763 |
Sentence |
denotes |
To facilitate studies on domain organization and its importance for biological function a strategy was developed to chemically conjugate defined heparin oligomers in linear and chemoselective fashion. |
| T5 |
563-763 |
Sentence |
denotes |
To facilitate studies on domain organization and its importance for biological function a strategy was developed to chemically conjugate defined heparin oligomers in linear and chemoselective fashion. |
| T5 |
563-763 |
Sentence |
denotes |
To facilitate studies on domain organization and its importance for biological function a strategy was developed to chemically conjugate defined heparin oligomers in linear and chemoselective fashion. |
| TextSentencer_T6 |
764-1030 |
Sentence |
denotes |
The procedure requires that the oligosaccharide to provide the reducing-terminal domain of the conjugate is generated by lyase degradation of a parent polysaccharide, whereas the nonreducing-terminal domain is obtained through deaminative cleavage with nitrous acid. |
| T6 |
764-1030 |
Sentence |
denotes |
The procedure requires that the oligosaccharide to provide the reducing-terminal domain of the conjugate is generated by lyase degradation of a parent polysaccharide, whereas the nonreducing-terminal domain is obtained through deaminative cleavage with nitrous acid. |
| T6 |
764-1030 |
Sentence |
denotes |
The procedure requires that the oligosaccharide to provide the reducing-terminal domain of the conjugate is generated by lyase degradation of a parent polysaccharide, whereas the nonreducing-terminal domain is obtained through deaminative cleavage with nitrous acid. |
| TextSentencer_T7 |
1031-1273 |
Sentence |
denotes |
The applicability of the method was demonstrated by constructing a conjugate composed of two heparin 12-mers, of which the reducing-terminal component contained the antithrombin-binding region, whereas the nonreducing-terminal domain did not. |
| T7 |
1031-1273 |
Sentence |
denotes |
The applicability of the method was demonstrated by constructing a conjugate composed of two heparin 12-mers, of which the reducing-terminal component contained the antithrombin-binding region, whereas the nonreducing-terminal domain did not. |
| T7 |
1031-1273 |
Sentence |
denotes |
The applicability of the method was demonstrated by constructing a conjugate composed of two heparin 12-mers, of which the reducing-terminal component contained the antithrombin-binding region, whereas the nonreducing-terminal domain did not. |
| TextSentencer_T8 |
1274-1411 |
Sentence |
denotes |
Contrary to any of the unconjugated oligomers, the product was found to efficiently promote the inactivation of thrombin by antithrombin. |
| T8 |
1274-1411 |
Sentence |
denotes |
Contrary to any of the unconjugated oligomers, the product was found to efficiently promote the inactivation of thrombin by antithrombin. |
| T8 |
1274-1411 |
Sentence |
denotes |
Contrary to any of the unconjugated oligomers, the product was found to efficiently promote the inactivation of thrombin by antithrombin. |